Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2001 1
2005 1
2020 4
2021 5
2022 5
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Magnetic Resonance-Guided Adaptive Radiation therapy for Prostate Cancer: The First Results from the MOMENTUM study-An International Registry for the Evidence-Based Introduction of Magnetic Resonance-Guided Adaptive Radiation Therapy.
Teunissen FR, Willigenburg T, Tree AC, Hall WA, Choi SL, Choudhury A, Christodouleas JP, de Boer JCJ, de Groot-van Breugel EN, Kerkmeijer LGW, Pos FJ, Schytte T, Vesprini D, Verkooijen HM, van der Voort van Zyp JRN. Teunissen FR, et al. Among authors: willigenburg t. Pract Radiat Oncol. 2022 Nov 30:S1879-8500(22)00363-0. doi: 10.1016/j.prro.2022.09.007. Online ahead of print. Pract Radiat Oncol. 2022. PMID: 36462619 Free article.
Clinical application of a sub-fractionation workflow for intrafraction re-planning during prostate radiotherapy treatment on a 1.5 Tesla MR-Linac: A practical method to mitigate intrafraction motion.
Willigenburg T, Zachiu C, Bol GH, de Groot-van Beugel EN, Lagendijk JJW, van der Voort van Zyp JRN, Raaymakers BW, de Boer JCJ. Willigenburg T, et al. Radiother Oncol. 2022 Nov;176:25-30. doi: 10.1016/j.radonc.2022.09.004. Epub 2022 Sep 14. Radiother Oncol. 2022. PMID: 36113777 Free article.
The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating 'trials within cohorts' (TwiCs) for the evaluation of interventions for prostate cancer.
Teunissen FR, Willigenburg T, Meijer RP, van Melick HHE, Verkooijen HM, van der Voort van Zyp JRN. Teunissen FR, et al. Among authors: willigenburg t. World J Urol. 2022 Sep;40(9):2205-2212. doi: 10.1007/s00345-022-04092-2. Epub 2022 Jul 21. World J Urol. 2022. PMID: 35861861 Free PMC article. Clinical Trial.
Accumulated bladder wall dose is correlated with patient-reported acute urinary toxicity in prostate cancer patients treated with stereotactic, daily adaptive MR-guided radiotherapy.
Willigenburg T, van der Velden JM, Zachiu C, Teunissen FR, Lagendijk JJW, Raaymakers BW, de Boer JCJ, van der Voort van Zyp JRN. Willigenburg T, et al. Radiother Oncol. 2022 Jun;171:182-188. doi: 10.1016/j.radonc.2022.04.022. Epub 2022 Apr 28. Radiother Oncol. 2022. PMID: 35489444 Free article.
Comparison of Library of Plans with two daily adaptive strategies for whole bladder radiotherapy.
den Boer D, den Hartogh MD, Kotte ANTJ, van der Voort van Zyp JRN, Noteboom JL, Bol GH, Willigenburg T, Werensteijn-Honingh AM, Jürgenliemk-Schulz IM, van Lier ALHMW, Kroon PS. den Boer D, et al. Among authors: willigenburg t. Phys Imaging Radiat Oncol. 2021 Nov 20;20:82-87. doi: 10.1016/j.phro.2021.11.002. eCollection 2021 Oct. Phys Imaging Radiat Oncol. 2021. PMID: 34849413 Free PMC article.
Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients.
Teunissen FR, Wortel RC, Hes J, Willigenburg T, de Groot-van Breugel EN, de Boer JCJ, van Melick HHE, Verkooijen HM, van der Voort van Zyp JRN. Teunissen FR, et al. Among authors: willigenburg t. Phys Imaging Radiat Oncol. 2021 Sep 21;20:5-10. doi: 10.1016/j.phro.2021.09.002. eCollection 2021 Oct. Phys Imaging Radiat Oncol. 2021. PMID: 34604553 Free PMC article.
Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer.
Willigenburg T, van Son MJ, van de Pol SMG, Eppinga WSC, Lagendijk JJW, de Boer HCJ, Moerland MA, van der Voort van Zyp JRN, Peters M. Willigenburg T, et al. Clin Transl Radiat Oncol. 2021 Jun 29;30:7-14. doi: 10.1016/j.ctro.2021.06.005. eCollection 2021 Sep. Clin Transl Radiat Oncol. 2021. PMID: 34278009 Free PMC article.
18 results